How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Give kids a chance act H.R.1262; issues related to rare pediatric disease and priority review vouchers
Give kids a chance act H.R.1262; issues related to rare pediatric disease and priority review vouchers
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
FORTRESS BIOTECH INC. via THE VOGEL GROUP
2026 · second_quarter · 2T
Give kids a chance act H.R.1262; issues related to rare pediatric disease and priority review vouchers
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
FORTRESS BIOTECH INC. via THE VOGEL GROUP
2026 · first_quarter · Q1
Source: Senate LDA
Give kids a chance act H.R.1262; issues related to rare pediatric disease and priority review vouchers
Give kids a chance act H.R.1262; issues related to rare pediatric disease and priority review vouchers
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
FORTRESS BIOTECH INC. via THE VOGEL GROUP
2025 · fourth_quarter · Q4
Give kids a chance act H.R.1262; issues related to rare pediatric disease and priority review vouchers
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office